Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Internal Medicine, HagaZiekenhuis, The Hague, The Netherlands.
Rev Med Virol. 2023 Jan;33(1):e2393. doi: 10.1002/rmv.2393. Epub 2022 Sep 3.
Balancing immunosuppression to prevent rejection in solid organ transplant (SOT) recipients remains challenging. Torque teno virus (TTV), a commensal non-pathogenic virus, has been proposed as marker of functional immunity: higher loads correspond to over-immunosuppression, and lower loads to under-immunosuppression. This review offers an overview of the current evidence of the association between TTV-load and infection and rejection after SOT. A systematic literature search strategy, deposited in the PROSPERO registry, resulted in 548 records. After screening, 23 original and peer-reviewed articles were assessed investigating the association between TTV-load, infection and/or rejection in SOT. The Quality in Prognostic Studies (QUIPS)-tool was used to assess the risk of bias. Meta-analysis with random-effects was performed on results with similar outcomes and exposure measures. Most of the included studies involved retrospective cohorts in which the TTV-load was measured longitudinally, within the first 2 years post-transplantation. Infection outcomes differed between studies and included viral, bacterial, parasitic and fungal infections. Rejection was defined by biopsy confirmation or initiation of rejection treatment. Twelve out of 16 studies reported an association between high TTV-load and infections, whereas 13 out of 15 reported an association between low TTV-load and rejection. Meta-analysis showed an increased risk of infection (OR: 1.16, 95% CI: 1.03-1.32; HR: 1.05, 95% CI: 0.97-1.14) and a decreased risk of rejection (OR: 0.90, 95% CI: 0.87-0.94; HR: 0.74, 95% CI: 0.71-0.76) per 1 log TTV-load increase. The qualitative assessment showed varying risks of bias in the included studies. This systematic review and meta-analysis indicates that blood TTV-load measured within the first 2 years after SOT is associated with the risk of infection or allograft rejection, although substantial risk of bias in the studies included warrant cautious interpretation. The results in this review provide a rationale for larger, prospective, studies into TTV as marker of infection and rejection after SOT.
在实体器官移植(SOT)受者中,平衡免疫抑制以预防排斥反应仍然具有挑战性。Torque teno 病毒(TTV)是一种共生的非致病性病毒,已被提议作为功能性免疫的标志物:较高的负荷对应于过度免疫抑制,而较低的负荷对应于免疫抑制不足。这篇综述概述了 TTV 负荷与 SOT 后感染和排斥反应之间关联的现有证据。系统的文献检索策略在 PROSPERO 注册中心中进行,结果得到了 548 条记录。经过筛选,评估了 23 篇原始和同行评议的文章,这些文章调查了 TTV 负荷、感染和/或 SOT 排斥反应之间的关联。使用预后研究质量(QUIPS)工具评估偏倚风险。对具有相似结局和暴露测量的结果进行了随机效应荟萃分析。大多数纳入的研究涉及回顾性队列,其中 TTV 负荷在移植后 2 年内进行了纵向测量。感染结局在研究之间有所不同,包括病毒、细菌、寄生虫和真菌感染。排斥反应通过活检证实或开始排斥反应治疗来定义。16 项研究中有 12 项报告了高 TTV 负荷与感染之间的关联,而 15 项研究中有 13 项报告了低 TTV 负荷与排斥反应之间的关联。荟萃分析显示感染风险增加(OR:1.16,95%CI:1.03-1.32;HR:1.05,95%CI:0.97-1.14)和排斥反应风险降低(OR:0.90,95%CI:0.87-0.94;HR:0.74,95%CI:0.71-0.76)每增加 1 个 TTV 负荷对数。定性评估显示纳入研究存在不同的偏倚风险。这项系统综述和荟萃分析表明,SOT 后 2 年内测量的血液 TTV 负荷与感染或同种异体移植排斥反应的风险相关,尽管纳入研究存在较大的偏倚风险,但需要谨慎解释。本综述中的结果为更大规模的前瞻性研究提供了依据,研究 TTV 作为 SOT 后感染和排斥反应的标志物。